Loading…
Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
Seyedpour, Simin, Khodaei, Behzad, Loghman, Amir H., Seyedpour, Nasrin, Kisomi, Misagh F., Balibegloo, Maryam, Nezamabadi, Sasan S., Gholami, Bahareh, Saghazadeh, Amene, Rezaei, Nima
Published in Journal of cellular physiology (01.04.2021)
Published in Journal of cellular physiology (01.04.2021)
Get full text
Journal Article
Loading…
Cholesterol 25-hydroxylase acts as a host restriction factor on pseudorabies virus replication
Wang, Jiang, Zeng, Lei, Zhang, Li, Guo, Zhen-Zhen, Lu, Shao-Fang, Ming, Sheng-Li, Li, Guo-Li, Wan, Bo, Tian, Ke-Gong, Yang, Guo-Yu, Chu, Bei-Bei
Published in Journal of general virology (01.06.2017)
Published in Journal of general virology (01.06.2017)
Get full text
Journal Article
Loading…
Loading…
Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection
Beitari, Saina, Pan, Qinghua, Finzi, Andrés, Liang, Chen
Published in Journal of virology (30.07.2020)
Published in Journal of virology (30.07.2020)
Get full text
Journal Article
Loading…
Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells
Caohuy, Hung, Eidelman, Ofer, Chen, Tinghua, Liu, Shufeng, Yang, Qingfeng, Bera, Alakesh, Walton, Nathan I., Wang, Tony T., Pollard, Harvey B.
Published in Scientific reports (12.11.2021)
Published in Scientific reports (12.11.2021)
Get full text
Journal Article
Loading…
A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
Fibriansah, Guntur, Tan, Joanne L, Smith, Scott A, de Alwis, Adamberage R, Ng, Thiam‐Seng, Kostyuchenko, Victor A, Ibarra, Kristie D, Wang, Jiaqi, Harris, Eva, de Silva, Aravinda, Crowe, James E, Lok, Shee‐Mei
Published in EMBO molecular medicine (01.03.2014)
Published in EMBO molecular medicine (01.03.2014)
Get full text
Journal Article
Loading…
The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Covino, Daniela Angela, Sabbatucci, Michela, Fantuzzi, Laura
Published in Current drug targets (01.01.2016)
Published in Current drug targets (01.01.2016)
Get more information
Journal Article
Loading…
Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor
Chen, Yingying, Wang, Xinchen, Zhu, Yinbiao, Si, Longlong, Zhang, Bo, Zhang, Yongmin, Zhang, Lihe, Zhou, Demin, Xiao, Sulong
Published in Molecular pharmaceutics (06.07.2020)
Published in Molecular pharmaceutics (06.07.2020)
Get full text
Journal Article
Loading…
V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance
Wu, Ellen, Du, Yueqi, Gao, Xiang, Zhang, Jie, Martin, John, Mitreva, Makedonka, Ratner, Lee
Published in Journal of virology (01.05.2019)
Published in Journal of virology (01.05.2019)
Get full text
Journal Article
Loading…
Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
Sharifkashani, Sourena, Bafrani, Melika Arab, Khaboushan, Alireza Soltani, Pirzadeh, Marzieh, Kheirandish, Ali, Yavarpour_Bali, Hanie, Hessami, Amirhossein, Saghazadeh, Amene, Rezaei, Nima
Published in European journal of pharmacology (05.10.2020)
Published in European journal of pharmacology (05.10.2020)
Get full text
Journal Article
Loading…
Loading…
Loading…
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
Roche, Michael, Salimi, Hamid, Duncan, Renee, Wilkinson, Brendan L, Chikere, Kelechi, Moore, Miranda S, Webb, Nicholas E, Zappi, Helena, Sterjovski, Jasminka, Flynn, Jacqueline K, Ellett, Anne, Gray, Lachlan R, Lee, Benhur, Jubb, Becky, Westby, Mike, Ramsland, Paul A, Lewin, Sharon R, Payne, Richard J, Churchill, Melissa J, Gorry, Paul R
Published in Retrovirology (20.04.2013)
Published in Retrovirology (20.04.2013)
Get full text
Journal Article
Loading…
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
Welén, Karin, Överby, Anna K, Ahlm, Clas, Freyhult, Eva, Robinsson, David, Henningsson, Anna Jonsson, Stranne, Johan, Bremell, Daniel, Angelin, Martin, Lindquist, Elisabeth, Buckland, Robert, Carlsson, Camilla Thellenberg, Pauksens, Karlis, Bill-Axelsson, Anna, Akre, Olof, Ryden, Cecilia, Wagenius, Magnus, Bjartell, Anders, Nilsson, Anna C., Styrke, Johan, Repo, Johanna, Balkhed, Åse Östholm, Niward, Katarina, Gisslén, Magnus, Josefsson, Andreas
Published in Current controlled trials in cardiovascular medicine (16.03.2021)
Published in Current controlled trials in cardiovascular medicine (16.03.2021)
Get full text
Journal Article
Loading…
Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
Kawana-Tachikawa, Ai, Llibre, Josep M., Bravo, Isabel, Escrig, Roser, Mothe, Beatriz, Puig, Jordi, Puertas, Maria C., Martinez-Picado, Javier, Blanco, Julia, Manzardo, Christian, Miro, Jose M., Iwamoto, Aikichi, Pozniak, Anton L., Gatell, Jose M., Clotet, Bonaventura, Brander, Christian
Published in PloS one (27.01.2014)
Published in PloS one (27.01.2014)
Get full text
Journal Article
Loading…
3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry
Li, Lin, Qiu, Jiayin, Lu, Lu, An, Shengli, Qiao, Pengyuan, Jiang, Shibo, Liu, Shuwen
Published in Journal of antimicrobial chemotherapy (01.03.2013)
Published in Journal of antimicrobial chemotherapy (01.03.2013)
Get full text
Journal Article